Progenics Pharmaceuticals, Inc. announced the appointment of Bryce V. Tenbarge as Vice President of Commercial, effective August 22, 2016. In this newly created role, Mr. Tenbarge will report to Mark Baker, Chief Executive Officer of the company, and will be responsible for leading all of the company’s commercial activities. Mr. Tenbarge brings over fifteen years of experience in biopharmaceutical marketing, most recently as Vice President of Marketing and Commercialization at Celldex Therapeutics. Tenbarge joins the company from Celldex Therapeutics, where he served as Vice President of Marketing and Commercialization since 2013.